Published 13 Dec 2022
Aspen Pharma Group has announced that it will receive USD30 million from the Bill & Melinda Gates Foundation and the Coalition for Epidemic Preparedness Innovations (CEPI) to support its capabilities to manufacture lifesaving routine and outbreak vaccines in Africa for Africa.
Stephen Saad, Aspen Group Chief Executive, said “This is an important first step in ensuring expanded and enduring equitable access to a pipeline of medicines and vaccines manufactured in Africa for Africans. Aspen has a proven capability of being at the forefront of pandemic preparedness for the Continent – from ARVs to COVID vaccines. This support will ensure we can continue to invest and expand our capacities, secure in the knowledge of future offtakes.”
Read the full press release on website of Aspen Pharma Group
